Kinnate Biopharma Inc (DELISTED) (KNTE:DL)
2.65
0.00 (0.00%)
USD |
NASDAQ |
Apr 03, 16:00
Kinnate Biopharma Cash and Short Term Investments (Quarterly): 154.03M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 154.03M |
| September 30, 2023 | 167.58M |
| June 30, 2023 | 184.70M |
| March 31, 2023 | 200.98M |
| December 31, 2022 | 201.48M |
| September 30, 2022 | 230.98M |
| June 30, 2022 | 233.00M |
| March 31, 2022 | 239.26M |
| Date | Value |
|---|---|
| December 31, 2021 | 219.46M |
| September 30, 2021 | 223.23M |
| June 30, 2021 | 220.01M |
| March 31, 2021 | 248.20M |
| December 31, 2020 | 396.86M |
| September 30, 2020 | 156.86M |
| December 31, 2019 | 76.45M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
76.45M
Minimum
Dec 2019
396.86M
Maximum
Dec 2020
210.20M
Average
219.46M
Median
Dec 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| XOMA Corp | 136.64M |
| Societal CDMO Inc (DELISTED) | 8.095M |
| NGM Biopharmaceuticals Inc (DELISTED) | 144.18M |
| Avrobio Inc | 90.48M |
| Landos Biopharma Inc (DELISTED) | 29.00M |